Comparing tests for CMV in bowel disease patients
Part of Digestive system clinical trials.
This trial compares different diagnostic tests to find the best way to detect cytomegalovirus (CMV) organ disease in people with inflammatory bowel disease (IBD) whose symptoms get worse and need hospital care. The goal is to improve diagnosis and treatment for this complication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis
- Your IBD symptoms have recently gotten worse enough that you need to be in the hospital
- You are scheduled to have a colonoscopy with biopsies (tissue samples) to check for CMV infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a simple test can help doctors tell the difference between conditions that cause long-term gut problems, like irritable bowel syndrome (a functional disorder) and inflammatory bowel disease (a disease that causes inflammation). It aims to find a way to diagnose without invasive procedures, which could lead to faster and more comfortable diagnosis for patients.
This study tests if a standard ultrasound is as good as a high-end one at seeing inflammation in the gut. It could help people with IBD avoid more invasive procedures.
This study looks at how certain blood cells change during a severe flare-up of inflammatory bowel disease (IBD), like Crohn's disease or ulcerative colitis. The goal is to better understand inflammation and potentially improve future treatments.
This study looks at how doctors diagnose inflammatory bowel disease (IBD), a condition that causes inflammation in the digestive tract. It may help improve diagnosis and care for people with IBD.
This trial compares how well different combinations of drugs calm inflammation in the gut compared to single drugs. It uses tissue samples taken during a colonoscopy to see which approach works best for people with inflammatory bowel disease.
This study checks whether a blood test (QuantiFERON-CMV, related to prior CMV infection) can predict if CMV might reactivate during a severe ulcerative colitis flare. It may help doctors spot people at higher risk and potentially guide monitoring and treatment during hospitalization.
Hear when a new Cytomegalovirus (CMV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.